352 related articles for article (PubMed ID: 8823312)
1. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.
Schissel SL; Tweedie-Hardman J; Rapp JH; Graham G; Williams KJ; Tabas I
J Clin Invest; 1996 Sep; 98(6):1455-64. PubMed ID: 8823312
[TBL] [Abstract][Full Text] [Related]
2. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development.
Schissel SL; Jiang X; Tweedie-Hardman J; Jeong T; Camejo EH; Najib J; Rapp JH; Williams KJ; Tabas I
J Biol Chem; 1998 Jan; 273(5):2738-46. PubMed ID: 9446580
[TBL] [Abstract][Full Text] [Related]
3. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix.
Marathe S; Kuriakose G; Williams KJ; Tabas I
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2648-58. PubMed ID: 10559007
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation.
Tabas I; Li Y; Brocia RW; Xu SW; Swenson TL; Williams KJ
J Biol Chem; 1993 Sep; 268(27):20419-32. PubMed ID: 8376399
[TBL] [Abstract][Full Text] [Related]
5. Sphingomyelinase activity of LDL: a link between atherosclerosis, ceramide, and apoptosis?
Kinnunen PK; Holopainen JM
Trends Cardiovasc Med; 2002 Jan; 12(1):37-42. PubMed ID: 11796243
[TBL] [Abstract][Full Text] [Related]
6. Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice fed on a high-fat diet.
Deevska GM; Sunkara M; Morris AJ; Nikolova-Karakashian MN
Biosci Rep; 2012 Oct; 32(5):479-90. PubMed ID: 22712892
[TBL] [Abstract][Full Text] [Related]
7. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.
Jeong Ts; Schissel SL; Tabas I; Pownall HJ; Tall AR; Jiang X
J Clin Invest; 1998 Feb; 101(4):905-12. PubMed ID: 9466986
[TBL] [Abstract][Full Text] [Related]
8. Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans.
Oörni K; Posio P; Ala-Korpela M; Jauhiainen M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1678-83. PubMed ID: 15879301
[TBL] [Abstract][Full Text] [Related]
9. Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles. Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans.
Oörni K; Hakala JK; Annila A; Ala-Korpela M; Kovanen PT
J Biol Chem; 1998 Oct; 273(44):29127-34. PubMed ID: 9786921
[TBL] [Abstract][Full Text] [Related]
10. Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-Ketocholesterol.
Maor I; Mandel H; Aviram M
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1378-87. PubMed ID: 7670952
[TBL] [Abstract][Full Text] [Related]
11. Effect of sphingomyelinase-mediated generation of ceramide on aggregation of low-density lipoprotein.
Walters MJ; Wrenn SP
Langmuir; 2008 Sep; 24(17):9642-7. PubMed ID: 18671414
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic roles of lipoprotein lipase and sphingomyelinase in low density lipoprotein aggregation.
Walters MJ; Wrenn SP
J Colloid Interface Sci; 2011 Nov; 363(1):268-74. PubMed ID: 21839462
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-released proteoglycans enhance LDL aggregation: studies in aorta from apolipoprotein E-deficient mice.
Maor I; Hayek T; Hirsh M; Iancu TC; Aviram M
Atherosclerosis; 2000 May; 150(1):91-101. PubMed ID: 10781639
[TBL] [Abstract][Full Text] [Related]
14. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression.
Devlin CM; Leventhal AR; Kuriakose G; Schuchman EH; Williams KJ; Tabas I
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1723-30. PubMed ID: 18669882
[TBL] [Abstract][Full Text] [Related]
15. Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation.
Marathe S; Choi Y; Leventhal AR; Tabas I
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2607-13. PubMed ID: 11116060
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation.
Nguyen SD; Javanainen M; Rissanen S; Zhao H; Huusko J; Kivelä AM; Ylä-Herttuala S; Navab M; Fogelman AM; Vattulainen I; Kovanen PT; Öörni K
J Lipid Res; 2015 Jun; 56(6):1206-21. PubMed ID: 25861792
[TBL] [Abstract][Full Text] [Related]
17. Ceramide in lipid particles enhances heparan sulfate proteoglycan and low density lipoprotein receptor-related protein-mediated uptake by macrophages.
Morita SY; Kawabe M; Sakurai A; Okuhira K; Vertut-Doï A; Nakano M; Handa T
J Biol Chem; 2004 Jun; 279(23):24355-61. PubMed ID: 15044445
[TBL] [Abstract][Full Text] [Related]
18. Sphingomyelinase treatment of low density lipoprotein and cultured cells results in enhanced processing of LDL which can be modulated by sphingomyelin.
Gupta AK; Rudney H
J Lipid Res; 1992 Dec; 33(12):1741-52. PubMed ID: 1479284
[TBL] [Abstract][Full Text] [Related]
19. Sphingomyelinase and membrane sphingomyelin content: determinants ofProximal tubule cell susceptibility to injury.
Zager RA; Burkhart KM; Johnson A
J Am Soc Nephrol; 2000 May; 11(5):894-902. PubMed ID: 10770967
[TBL] [Abstract][Full Text] [Related]
20. Neutral sphingomyelinase.
Chatterjee S
Adv Lipid Res; 1993; 26():25-48. PubMed ID: 8379453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
